Cargando…

Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis

BACKGROUND: The correlation between benign thyroid disease (BTD) and breast cancer (BC) has long been discussed. However, the definite relationship and potential mechanism between them are still disputed. The current meta-analysis aimed at performing a comprehensive assessment of the relationship be...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Mingyue, Wang, Yao, Jin, Yuanhui, Zhao, Xue, Cui, Haiying, Wang, Guixia, Gang, Xiaokun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596990/
https://www.ncbi.nlm.nih.gov/pubmed/36313770
http://dx.doi.org/10.3389/fendo.2022.984593
_version_ 1784815993303859200
author Han, Mingyue
Wang, Yao
Jin, Yuanhui
Zhao, Xue
Cui, Haiying
Wang, Guixia
Gang, Xiaokun
author_facet Han, Mingyue
Wang, Yao
Jin, Yuanhui
Zhao, Xue
Cui, Haiying
Wang, Guixia
Gang, Xiaokun
author_sort Han, Mingyue
collection PubMed
description BACKGROUND: The correlation between benign thyroid disease (BTD) and breast cancer (BC) has long been discussed. However, the definite relationship and potential mechanism between them are still disputed. The current meta-analysis aimed at performing a comprehensive assessment of the relationship between different types of benign thyroid disease and the risk of breast cancer, furthermore, assessing whether benign thyroid disease exerts an influence on the aggressiveness of breast cancer. METHOD: A systematic literature search (PubMed, Web of Science, MEDLINE, and Embase databases) identified studies to evaluate the correlation between BTD and BC risk. Data were analyzed using version 16.0 STATA software, including the odds ratio (OR) and its corresponding 95% confidence intervals (CIs). Publication bias and quality assessment were conducted for the included studies. RESULT: Overall, 18 studies involving 422,384 patients with BTD were incorporated. The outcome showed that autoimmune thyroiditis (OR: 2.56, 95%CI: 1.95–3.37, I(2 =) 0.0%, p=0.460), goiter (OR: 2.13, 95%CI: 1.19-3.79, I(2 =) 80.6%, p=0.000), and Graves’ disease (OR: 5.01, 95%CI: 1.49-16.82, I(2 =) 0.0%, p=0.358) was connected with a higher risk of BC. Both hypothyroidism (OR: 0.82, 95%CI: 0.64-1.04, I(2 =) 85.0%, p=0.000) and hyperthyroidism (OR: 1.07, 95%CI: 0.93-1.24, I(2 =) 24.9%, p=0.206) had no significant association with the risk of BC. Additionally, the pooled analysis showed no apparent correlation between BTD and aggressiveness of BC. However, subgroup analysis indicated a positive relationship between BTD and aggressiveness of BC in the Europe subgroup (HR: 2.05, 95%CI: 1.32-3.17, I(2 =) 86.4%, p=0.000). CONCLUSION: Autoimmune thyroiditis, goiter, and Graves’ disease are connected with an increased risk of BC. Furthermore, subgroup analysis suggested that BTD increases the aggressiveness of BC in the European population geographically. Nevertheless, further research is needed to prove these discoveries.
format Online
Article
Text
id pubmed-9596990
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95969902022-10-27 Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis Han, Mingyue Wang, Yao Jin, Yuanhui Zhao, Xue Cui, Haiying Wang, Guixia Gang, Xiaokun Front Endocrinol (Lausanne) Endocrinology BACKGROUND: The correlation between benign thyroid disease (BTD) and breast cancer (BC) has long been discussed. However, the definite relationship and potential mechanism between them are still disputed. The current meta-analysis aimed at performing a comprehensive assessment of the relationship between different types of benign thyroid disease and the risk of breast cancer, furthermore, assessing whether benign thyroid disease exerts an influence on the aggressiveness of breast cancer. METHOD: A systematic literature search (PubMed, Web of Science, MEDLINE, and Embase databases) identified studies to evaluate the correlation between BTD and BC risk. Data were analyzed using version 16.0 STATA software, including the odds ratio (OR) and its corresponding 95% confidence intervals (CIs). Publication bias and quality assessment were conducted for the included studies. RESULT: Overall, 18 studies involving 422,384 patients with BTD were incorporated. The outcome showed that autoimmune thyroiditis (OR: 2.56, 95%CI: 1.95–3.37, I(2 =) 0.0%, p=0.460), goiter (OR: 2.13, 95%CI: 1.19-3.79, I(2 =) 80.6%, p=0.000), and Graves’ disease (OR: 5.01, 95%CI: 1.49-16.82, I(2 =) 0.0%, p=0.358) was connected with a higher risk of BC. Both hypothyroidism (OR: 0.82, 95%CI: 0.64-1.04, I(2 =) 85.0%, p=0.000) and hyperthyroidism (OR: 1.07, 95%CI: 0.93-1.24, I(2 =) 24.9%, p=0.206) had no significant association with the risk of BC. Additionally, the pooled analysis showed no apparent correlation between BTD and aggressiveness of BC. However, subgroup analysis indicated a positive relationship between BTD and aggressiveness of BC in the Europe subgroup (HR: 2.05, 95%CI: 1.32-3.17, I(2 =) 86.4%, p=0.000). CONCLUSION: Autoimmune thyroiditis, goiter, and Graves’ disease are connected with an increased risk of BC. Furthermore, subgroup analysis suggested that BTD increases the aggressiveness of BC in the European population geographically. Nevertheless, further research is needed to prove these discoveries. Frontiers Media S.A. 2022-10-12 /pmc/articles/PMC9596990/ /pubmed/36313770 http://dx.doi.org/10.3389/fendo.2022.984593 Text en Copyright © 2022 Han, Wang, Jin, Zhao, Cui, Wang and Gang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Han, Mingyue
Wang, Yao
Jin, Yuanhui
Zhao, Xue
Cui, Haiying
Wang, Guixia
Gang, Xiaokun
Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis
title Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis
title_full Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis
title_fullStr Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis
title_full_unstemmed Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis
title_short Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis
title_sort benign thyroid disease and the risk of breast cancer: an updated systematic review and meta-analysis
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596990/
https://www.ncbi.nlm.nih.gov/pubmed/36313770
http://dx.doi.org/10.3389/fendo.2022.984593
work_keys_str_mv AT hanmingyue benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis
AT wangyao benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis
AT jinyuanhui benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis
AT zhaoxue benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis
AT cuihaiying benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis
AT wangguixia benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis
AT gangxiaokun benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis